Your session is about to expire
← Back to Search
Walking with personalized rhythmic auditory stimulation for Parkinson's Disease
Study Summary
This trial will study if rhythmic auditory stimulation, a rehabilitation approach coupling auditory cues with movement, can improve walking ability in people with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the eligibility criteria for this trial include participants of 30 years or greater age?
"To meet the requirements for this medical research, enrollees must be between 18 and 80 years old. For minors or those over 65 there are 26 trials specifically designed for them respectively."
Is Walking with personalized rhythmic auditory stimulation a risk-free activity for people?
"Given the limited safety and efficacy data, our team at Power rated Walking with personalized rhythmic auditory stimulation a 1 on their scale from 1 to 3."
Is enrollment for this study currently being accepted?
"Indeed, current information on clinicaltrials.gov shows that this trial is actively searching for participants. It commenced recruitment on January 17th 2023 and was last updated February 20th 2023; it seeks to enroll 30 individuals from one location."
To whom does this clinical trial extend eligibility?
"The investigators of this trial are searching for 30 participants with a Parkinson's disease diagnosis, aged between 18 and 80. Essential requirements include being able to communicate effectively, having the capacity to walk unaccompanied for at least 6 minutes (with an assistive device such as a cane if necessary), and confirming their self-reported condition."
How many patients are participating in this study?
"Affirmative. Information hosted on clinicaltrials.gov alludes to this trial actively seeking out patients, which was first listed on January 17th 2023 and last updated February 20th 2023. The study requires 30 participants at one medical centre."
What is the goal of this trial?
"The primary goal of this study, assessed over [RAS-Baseline], is to measure stride time variability. Secondary measures include Ground Reaction Forces in terms of peak and impulse (%bw), Joint power expressed as ankle, knee and hip moment (W/kg) ,and gait speed differences observed during the 6MWT (m/s)."
Share this study with friends
Copy Link
Messenger